Periphagen Holdings' Unattributed Round

Periphagen Holdings raised a round of funding on March 31, 2014.

PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products for neurologic disorders with significant unmet medical need. T…

Articles about Periphagen Holdings' Unattributed Round: